Feigal, Tunis To Present At HHS Reg Reform Panel On FDA/CMS Partnerships
This article was originally published in The Gray Sheet
Executive Summary
Collaborative opportunities between FDA and the Centers for Medicare & Medicare Services for approving new technologies will be explored during the upcoming 1HHS Advisory Committee on Regulatory Reform's public hearing in Minneapolis
You may also be interested in...
FDA Should Turn Over AE Analysis Criteria To Firms – Boston Scientific Exec
Much of the analysis of device-related adverse event reports currently handled by FDA could be completed by device manufacturers if the agency provided the criteria, according to Boston Scientific Manager for Quality and Regulatory Compliance Kristin Johnson
FDA Should Turn Over AE Analysis Criteria To Firms – Boston Scientific Exec
Much of the analysis of device-related adverse event reports currently handled by FDA could be completed by device manufacturers if the agency provided the criteria, according to Boston Scientific Manager for Quality and Regulatory Compliance Kristin Johnson
Medicare Local, National Coverage Process Will Be Topic Of MTLF Meeting
Medtronic is sponsoring a Medical Technology Leadership Forum on Medicare local and national coverage decisions June 28